AGP Picks
View all

AGP Executive Report

Last update: 8 hours ago

China–Pakistan Health Tech: China and Pakistan unveiled a Zhejiang-Pakistan joint lab for herbal medicine R&D, aiming to deepen traditional medicine cooperation. Regulatory Milestone: Pakistan secured observer status at ICH, a step meant to modernize DRAP and align standards with global regulators. HIV Prevention Breakthrough: South Africa officially launched the twice-yearly injectable HIV prevention rollout of lenacapavir, backed by major Global Fund and CIFF funding. Cancer & Drug Policy: A U.S. Supreme Court ruling backed Hikma in a “skinny label” patent dispute over generic Vascepa, while a Los Angeles jury sided with J&J in a talc ovarian cancer case. Public Health Watch: India reported suspected Ebola in Jaipur with tests pending, and Argentina expanded its hantavirus outbreak investigation after a cruise-linked cluster. Care Access & Systems: Santa Clara County leaders urged state funding to protect public hospitals from looming federal cuts. Diabetes Prevention Tech: An EHR-based machine learning model flagged adults at high type 2 diabetes risk up to 10 years ahead.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Jun. 5, 2026

Yilda M. Acevedo leads PharmPR and pushes for women in Puerto Rico pharma

EIN Presswire

fallback image
Jun. 4, 2026

Women’s health market seen reaching $60.99 billion by 2030

EIN Presswire

fallback image
Jun. 3, 2026

SGS launches GMP-compliant NMR testing for China pharma industry

EIN Presswire

fallback image
May 6, 2026

Veterinary healthcare market seen reaching $315.63 billion by 2030

EIN Presswire


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Daniel Nadler – The Tech Entrepreneur Revolutionising the Medical Industry

Daniel Nadler – The Tech Entrepreneur Revolutionising the Medical Industry

Nature Echo Mushroom Gummies with Ashwagandha

Nature Echo Mushroom Gummies with Ashwagandha

As featured in:

@ Journalists!

Join

No journalists yet — this is a new service area. Join today!

Journalists Wanted

fallback image
Jun. 5, 2026

Yilda M. Acevedo, Recognized by Influential Women, Serves as Pharmaceutical Industry Leader and Founder of PharmPR Inc.

EIN Presswire

fallback image
Jun. 4, 2026

Women's Health Industry Report: Competitive Landscape and Future Prospects

EIN Presswire

fallback image
Jun. 3, 2026

SGS Launches GMP-Compliant NMR Testing for the Pharmaceutical Industry in China

EIN Presswire

fallback image
2 hours ago

RCP response to Lord Mann’s review of antisemitism and racism in the NHS

Royal College of Physicians

fallback image
5 hours ago

CMS releases updated report on complaint data, enforcement efforts 

American Hospital Association

fallback image
5 hours ago

AMA webinar recording on maternity care coding changes now available

American Hospital Association

More press releases

Video Stories

YouTube video thumbnail: Ebola Bundibugyo Strain Spreads Fast
Play
Ebola Bundibugyo Strain Spreads Fast
YouTube video thumbnail: Breakthrough Ovarian Cancer Drug Offers Patients More Time and Better Quality of Life
Play
Breakthrough Ovarian Cancer Drug Offers Patients More Time and Better Quality of Life
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: See one way Experts are Monitoring Infectious Disease Risks During the World Cup
Play
See one way Experts are Monitoring Infectious Disease Risks During the World Cup
YouTube video thumbnail: Abnormal Moles Seen Developing in Patients Using Peptide Melanotan-II
Play
Abnormal Moles Seen Developing in Patients Using Peptide Melanotan-II

Video Title

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.